January 24, 2023 eight:00 am Press Release LUGANO, Switzerland and STOCKHOLM, Sweden – January 24, 2023 – Helsinn Group (“Helsinn”), a fully built-in world wide biopharma organization with a history of over forty several years of business execution and a solid aim in oncology and unusual health conditions, and Immedica Pharma AB, a pharmace